ZBP1 and cutaneous mastocytosis: the expression of DIABLO and AURKA was negatively associated with the prognosis of CM patients, while ZBP1, GNLY, FASLG, TNFRSF21, and CD40LG were positively associated with survival (Figure 8V–AB).